Curriculum Vitae
George Khushf, Ph.D.
Professor, Department of Philosophy
Director, Center for Bioethics
University of South Carolina
Columbia, South Carolina 29208
USA
(803) 777-7371
[email protected]
Education
B.S.
Texas A&M University, College Station, Texas
Civil Engineering, summa cum laude, 1983
1988-89
Fulbright Award, University of Tübingen, Germany
Philosophy and Theology
M.A.
Rice University, Houston, Texas, 1990
Thesis topic: Kierkegaard and Hegel
Ph.D.
Rice University, Houston, Texas, with distinction, 1993
Dissertation topic: Hermeneutics
Academic Appointments
1989-95
Research Associate, Center for Medical Ethics and Health Policy
Baylor College of Medicine, Houston, Texas
1993-95
Managing Editor, The Journal of Medicine and Philosophy
Spring, 1995
Rockwell Visiting Professor
University of Houston, Houston, Texas
1995-
Professor (2010-p), Associate Professor (2002-10) and Assistant Professor
(1995-2002), Department of Philosophy, University of South Carolina
1995-
Director (2008-p) and Humanities Director (1995-08), Center for Bioethics,
University of South Carolina
2
Clinical Teaching
1992-95
Weekly consultative and instructional bioethics rounds at the medical intensive
care unit of Methodist Hospital in Houston, Texas. Instructional units taught to
Residents and Fellows included:
- Health Care Policy and Financing
- Advance Directives
- Informed Consent
- Withholding and Withdrawing Treatment
1993-95
Instructor in programs of the Center for Ethics, Medicine and Public Issues for
the education of medical students, Baylor College of Medicine. Classes taught
include:
- Ethical Problems in Obstetrics and Gynecology
- Ethical Issues in Neonatology
- Introduction to Clinical Medical Ethics
1996-
Medical Ethics and Administrative and Organizational Ethics, including monthly
ethics rounds for senior administrators of the Palmetto Health Alliance (since
1996) and diverse ethics education ranging from a second year medical ethics
course, professionalism in clinical practice, and various units for clinical
rotations at the Palmetto Health Alliance and University of South Carolina
School of Medicine, Columbia, South Carolina
Undergraduate and Graduate Teaching
1995-
Undergraduate courses in health care ethics, human enhancement, ethical theory,
philosophy of science and engineering, and logic, USC Department of
Philosophy, and a philosophy of technology course on catapults and cannons for
the USC Honors College
1995-
Graduate courses on health care ethics, philosophy of medicine, ethics,
metaphysics, and philosophy as a profession, USC Department of Philosophy
1997-2002
Founder and Director, Medical Humanities Program, including educational
opportunities in research, university lecture series, faculty discussion groups,
conferences, and organized and developed a minor in the medical humanities for
premedical students at the University of South Carolina
2000-2008
Primary Instructor, Ethics and the Health Sciences, a graduate course in
philosophy and cross-listed in the graduate programs of the schools of medicine,
nursing, pharmacy, public health, and social work
Ethics Committees
1995-10
1995-05
1996-01
2000-06
2001-05
South Carolina Medical Association Ethics Committee
Palmetto Richland Hospital Ethics Committee
Palmetto Senior Care Ethics Committee
Institutional Review Board (IRB), University of South Carolina
Animal Care and Use Committee, Veterans Administration Hospital and USC
3
School of Medicine
Professional Organizations
American Academy of Religion
Chair, Philosophy of Religion and Theology Section, Southwest Commission, 1993-95
American Philosophical Association
American Society for Bioethics and Humanities
Co-Chair, Program Committee, 1997-1998
Chair, Theoretical Medicine/Philosophy of Medicine Affinity Group, 2000-2005
Review of proposals related to organizational ethics, 2006-2010
Health Care Compliance Association
Region IV Board Member, 1998-1999
South Carolina State Liaison, 2000-2001
Society for Health and Human Values
Chair, Preconference Workshop, 1996-1997
South Carolina Medical Association
Consultant and Member, Medical Ethics Committee, 1995-2010
Coauthor of report on hospital credentialing, approved by SCMA Board, 1999
Selected University Service at USC
1995-96
1995-98
1996-98
1996-98
19961996
1996-97
1996-97
19971997-99
1998
2000
2000-2004
Ethics Search Committee, USC Department of Philosophy
Directed acquisitions for the Center for Bioethics library, including 20 journals
and several hundred books
Strategic Planning Committee for Graduate Medical Education, Palmetto
Richland Hospital and USC School of Medicine
Faculty Senate Representative, USC Department of Philosophy
Director, Monthly Bioethics Discussion Group for USC Faculty and Physicians
Co-organized and directed the conference Money and Medicine, including
nationally publicized calls for papers, evaluations of paper abstracts, invitation of
plenary speakers, organization of panels, and writing of needs assessments and
other requirements for Clinical Medical Education credits.
Provost’s Medical Humanities Committee
Chair, Subcommittee for drafting the Medical Humanities Minor
Medical Humanities Search Committee
Chair, Medical Humanities Committee
Director, Center for Bioethics program in summer research for undergraduate
students
Organized and directed a workshop for faculty teaching in the medical
humanities, conducted at Camp Saint Christopher, Seabrook Island, South
Carolina
Organized and directed the conference, “The Humanities in Medical Education.”
Keynote speakers were Bernard Lown (winner of 1985 Nobel Peace Prize) and
Edmund Pellegrino. Seventeen prominent bioethicists addressed the role of
humanities in medical education; performances were organized of a reader’s
theater, music and medicine, a tour of Columbia Museum of Art holdings related
to medicine, and an art exhibit by Deanna Leamon (a series of paintings on
anatomy).
Graduate Committee, Department of Philosophy
4
2000-2006
2003-2008
2004-2006
2004, 2006
2006-08
2012-p
2014-2015
Mentor, McNair Scholar Program
Team Leader, Ethics of Bionanotechnology, NIRT Team
Undergraduate Committee, Department of Philosophy
Chair, Bioethics Search Committee
Faculty Advisor, Medicus (student organization for discussing medical
ethics)
Chair, Values, Ethics and Social Responsibility (VSR) Committee,
Carolina Core Initiative, University of South Carolina
Chair, Epistemology Search Committee
Selected Professional and Public Service
1996
1996-99
19961997
1997
1998-00
1999
2000-2
2001-2
2001-3
2001-2
2001-4
2003-5
2004-6
2005-09
2005-11
2006-07
Consultant for Lexington Hospital, Irmo, South Carolina, for the establishment of
an ethics committee and ethics review mechanism
Advisory Board, Gifts of Life Trust Fund (to advance organ donation)
Work with media on bioethical issues, including television, newspapers, and
radio
Consultant for Loris Community Hospital, Loris, South Carolina, for the
establishment of an ethics committee and ethics review mechanism
Instructor, Summer School of Gerontology, Department of Health and Human
Services
Consultant, South Carolina Turning Point Initiative, a governmental strategic
planning process in public health, directed by the Department of Health and
Environmental Control
Consultant in organizational ethics, Greenville Hospital System, Greenville,
South Carolina
Consultant in clinical ethics, Colleton Medical Center, Walterboro, South
Carolina
Member, Task Force for the Reform of Medical Malpractice, South Carolina
Member, South Carolina Hospital Association Committee on Medical Mistakes
Member, Planning Committee, Pitts Memorial Conference “HIV/AIDS as an
Epidemic: Ethical Issues at the 20th Anniversary of the Epidemic,” Medical
University of South Carolina, Charleston, SC January 11-12, 2002; Also
Moderator of session on International AIDS funding.
Ethics Consultant for the South Carolina Department of Disabilities and Special
Needs
Expert Witness for the case, Cardiac Surgery Associates, P.A., et al., vs.
Midatlantic Cardiovascular Associates, P.A., in the Circuit Court for Baltimore
County (Case No. 03-C-01-010893)
Ethics Consultant, American College of Epidemiology, Concerning ethical issues
related to the necessity of a randomized controlled comparative survival trial for
chronic hemodialysis patients treated with Paricalcitol versus Calcitriol. Final
report published March 2006.
Steering Group Member, NanoBio-RAISE, a “Science and Society” program of
the European Commission Research Directorate-General to address ethics and
public communication related to nanobiotechnology (An overview of the project
is provided at www.nsti.org, Vol 2, 2005, pp. 765-768)
Member, Data Safety and Monitoring Board, Baromedical Research Foundation
Advisory Board Member, University of Pennsylvania Bioethics Center; this
5
2008-10
2009-14
2009-13
2010-p
2010-p
2010
2010
2010-11
2014
2014
2014
included attendance at meeting to evaluate the ethics initiative of the Penn
NSEC, Philadelphia, PA, June 12, 2006
Consultant, Lutheran Homes of South Carolina
Member, Scientific Advisory Committee (2009-13) and Strategic Advisory
Committee (2013-14), SynBERC: Synthetic Biology Engineering Research
Center, including review of internal grant proposals, consulting on emerging
issues related to ethics, judging of posters and participation at annual retreats
Working Group Member, NIH funded initiative: “Nanodiagnostics and
nanotherapeutics: building research ethics and oversight,” at University of
Minnesota, Minneapolis, including working group meetings in Minneapolis on
June 21-23, 2010; Nov 4-5, 2010.
Site visits with National Science Foundation (NSF) Nano Science and
Engineering Centers (NSECs), 2004-06, Engineering Research Centers (ERCs),
2008-09, and Science and Technology Center (STC), 2014.
Member, NIH/NLM Review Panel, Scholarly Works/Publication Grants (G13)
Review, Washington, DC, July 8-9, 2010 (57 proposals, with 5 written reviews),
and similar panels 2011, 2012, 2013, 2014
Member, Program Committee and Moderator of the Panel on animal research,
17th Annual Thomas A. Pitts Memorial Conference: From Laboratory to Bedside:
Ethical Issues in Clinical and Translational Research, MUSC, Charleston, SC,
October 29-30, 2010.
Co-organizer of conference, Communicating Across Cultures: Science,
Medicine, and Society, held Nov 10-11, 2010 in Columbia, SC
Member, Program Committee, Society for the Study of Nanoscience and
Emerging Technologies (S.NET)
Invited Participant in the Synthetic Biology Strategic Planning/Sustainability
Initiative, sponsored by Alfred P Sloan Foundation and conducted by Nancy J
Kelly Associates at the Chicago O’Hare Hilton, Chicago, IL, January 21, 2014.
Presented summary and drafted comments for final report on Biosafety and
Biosecurity working group, the Workshop on Research Agendas in the Societal
Aspects of Synthetic Biology, sponsored by the National Science Foundation,
Tempe Mission Palms, Tempe, AZ, November 4-6, 2014.
Co-organizer with Shai Lavi and Jeff Bishop (primary organizer) of the
conference on the Ends of Life: Deepening Reflection on the Ethical Issues at the
Beginning and End of Life, conducted at Tel Aviv University, Israel, June 8-10.
Grants and Awards
1983
1988-89
1991-92
1995-96
1996
Plumb Bob Award for Outstanding Student in Civil Engineering Practice, Texas
A&M University, College Station, Texas
Fulbright Award for study and research at the University of Tübingen, Germany
Dean’s Dissertation Award, Rice University
Grant for Southwest Regional Teaching Workshop, sponsored by Lilly
Foundation, National Endowment for the Humanities, and the American
Academy of Religion, August 7-13, October 13-15, 1995, and March 15-16,
1996.
Consultant (20% of my time with the Center for Bioethics, January 1-April 30) to
“Ethnic Variations in Attitudes Towards Hysterectomy, Oophorectomy, and
Surgical Menopause Among Women Ages 40 Plus,” Center for Disease Control,
Robert Mckeown, Chief Investigator
6
1996
1997-00
1998
1998-00
1999-02
2000-02
2000-02
2002-04
2002 -03
2003-07
2006-09
2009-10
2009-11
2008-P
2010-12
2013-15
Grant (matching funds) from the Educating Healthcare Ethics Committee
Program, Fund for the Improvement of Postsecondary Education, U.S.
Department of Education, Washington, DC, for the conducting of an educational
program for the Ethics Committee, Palmetto Richland Memorial Hospital, March
7-8.
Principal Investigator, “Training Physicians With Empathy: A Program in the
Medical Humanities for Premedical Students,” funded by the Fullerton
Foundation, $332,898.
Contract for conference, “Liberty, Tolerance, And Social Sanction” (a conference
on John Locke and J.S. Mill), funded by Liberty Fund, Inc.
Contract, “Concepts of Health and Disease, Values, and the SC Turning Point
Initiative,” funded by the South Carolina Department of Health and
Environmental Control, $7000.
Collaborating Scientist, Center for Research in Health Promotion and Risk
Reduction in Special Populations, National Institute for Nursing Research,
National Institutes of Health.
Consultant, Complementary and Alternative Medicine with Curative Intent,
Centers for Disease Control, $13,000.
Coinvestigator, Support to Establish and Fund the Center for the Philosophy and
Ethics of Complexity and Scale, $55,404.
Contract with South Carolina Department of Disabilities and Special Needs for
the provision of ethics consultation and educational services; $5,000 (cocontractor with Center for Bioethics).
Coinvestigator, NER: Philosophical and Social Dimensions of Nanoscale
Research - Developing a Rational Approach to a Newly Emerging Science and
Technology, National Science Foundation, $175,000.
Co-Principal Investigator, NIRT: From laboratory to society: developing an
informed approach to nanotechnology, National Science Foundation, $1,300,000.
Principal Investigator, “Complexity, systems, and control in nanobiotechnology:
Developing a framework for understanding and managing uncertainty associated
with radically disruptive technologies,” National Science Foundation, $200,000.
PI: Pate, R; Co-PIs: Eleazer, P; Khushf, G; Murday, D; Wilcox, S. “South
Carolina Clinical Translational Research Institute (CTSA subcontract with
MUSC)/National Institutes of Health, $101,610.
PI: M. Dickson, Co-PIs: D. Buxhoeveden and G. Khushf, “Consortium for
science, technology, health and society: Values, knowledge, and practice,” by
USC Office of Research (internal award), $83,972.
Principal Investigator/Contract with Palmetto Health Alliance to Fund the Center
for Bioethics; approx.. $120,000 per year since 2008.
Principal Investigator, “Upstream ethics in tissue biofabrication,” from SC
Research Authority (SCRA)/SC EPSCoR GEAR Award, $13,000.
Principal Investigator, “Fostering Conditions for the Flourishing of Big Science,”
GEAR Collaborative Research Program, SC EPSCoR/NSF, $95,182.
Grant Review
National Library of Medicine, Member, Publication Grant Review Panel, 2003-2007, 2009-2014
National Science Foundation, NSEC Review Panels, 2004-06; member of Site Visit Team,
ERC review panels 2008-09, 2014; STC Site Visit Team 2014, various reviews for SES –
Ethics and Values in Science, Engineering and Technology section, 2006f, and regular
7
requests for mail reviews
Welcome Trust, Review of Bioethics grants, 2005
Social Sciences and Humanities Research Council of Canada, 2005
Research Council of Norway, 2012
Editorial and Advisory
Advanced Science Letters
Editorial Board, 2008-Present
Christian Bioethics
Assistant Editor, 1994-1999
Advisory Board Member, 1999-Present
Ethical Theory and Moral Practice
Editorial Board Member, 1996-Present
Health Care Analysis
Editorial Board Member, 1998-Present
HEC Forum (Healthcare Ethics Committee Forum)
Section Editor, Administrative and Organizational Ethics, 1997-Present
Journal of Medicine and Philosophy
Assistant Managing Editor, 1992-1993
Managing Editor, 1993-1995
Assistant Editor, 1995-2005
Editorial Board, and Board of Directors Member, 1995-Present
Nanomedicine: Nanotechnology, Biology, and Medicine
Editorial Board Member, 2004-2007
Nanoethics: The Ethics of Technologies that Converge at the Nanoscale,
Editorial Board Member, 2007-Present
The Open Nanomedicine Journal
Editorial Board Member, 2009-Present
Organizational Intersections in Healthcare, Business and Policy
Editorial Board Member, 2003-2008
Journal of Law, Medicine and Ethics
Guest Editor (Winter 2006)
The International Library of Ethics, Law, and Technology (Springer book series)
Editorial Board Member, 2009-10
Reviewer
Extensive reviews in my editorial capacities and for journals and publishers such as:
American Journal of Managed Care; Annals of Thoracic Surgery; Hastings Center Report; Kennedy
Institute of Ethics Journal; Medicine, Healthcare and Philosophy; Philosophy of Science; Theoretical
Medicine and Bioethics; and book proposals for Georgetown University Press, Kluwer and now Springer,
and Oxford University Press.
Edited Book
Editor, Handbook of Bioethics (Kluwer Academic Publishers, 2004)
8
Edited Journal Issues
Issue editor, "The Ethical Foundations of Health Care Reform," Journal of Medicine and
Philosophy 19:5 (October, 1994).
Issue editor, "Reconceptualizing Health and Disease," Journal of Medicine and Philosophy 20:5
(October, 1995).
Issue editor, “Administrative and Organizational Ethics,” HEC Forum 10:2 (June, 1998)
Issue editor, “The Case for Managed Care,” Journal of Medicine and Philosophy 24:5 (October,
1999).
Issue editor with Rosemarie Tong, “Organizational Ethics,” HEC Forum 14:2 (June, 2002)
Guest Editor (with Robert Best and Robin Wilson), Symposium: Nanotechnology: Ethical, Legal
and Social Issues, The Journal of Law, Medicine, and Ethics 34(4) (2006)
Issue editor, “Ethics of NBIC Convergence for Enhancing Human Performance,” Journal of
Medicine and Philosophy (June 2007)
Issue editor, “Medical Epistemology,” Journal of Medicine and Philosophy 38 (2013)
Refereed Journal Articles, Book Chapters, and Review Essays
"Rights, Public Policy, and the State," in Rights to Health Care, ed. Thomas Bole and William
Bondeson (Kluwer Academic Publishers, 1991), pp. 355-374.
"Post-Modern Reflections on the Ethics of Naming," in The Ethics of Diagnosis, ed. Jose Luis
Peset and Diego Gracia (Kluwer Academic Publishers, 1992), pp. 275-300.
"Die Rolle des 'Buchstabens' in der Geschichte des Abendlands und im Christentum," in Schrift,
ed. H.U. Gumbrecht and K.L. Pfeiffer (Wilhelm-Fink-Verlag, 1993), pp. 21-33.
"The Meta-Ontological Option: On Taking the Existential Turn," in Hegel Reconsidered: Beyond
Metaphysics and the Authoritarian State, ed. H. Tristram Engelhardt and Terry Pinkard (Kluwer
Academic Publishers, 1994), pp. 119-142.
"Intolerant Tolerance," Journal of Medicine and Philosophy 19:2 (April, 1994), 161-181.
Translated into Italian and reprinted as: “Sulla tolleranza intollerante,” in Raffaella De
Franco (ed.), Bioetica E Tolleranza. Questioni di medicina e morale per il terzo millennio
(Levante Editori, 1998).
"Proportional Coinsurance: A Market Based, Ethically Sound Alternative to Medical Savings
Accounts," American Philosophical Association Newsletter on Philosophy and Medicine 93:1
(Spring, 1994), 84-87.
Review Essay of Alan Olson's Hegel and the Spirit: Philosophy as Pneumatology, in The Owl of
9
Minerva 26:1 (Fall, 1994), 71-77.
"Ethics, Politics, and Health Care Reform," Journal of Medicine and Philosophy 19:5 (October,
1994), 397-405.
"Grammacentrism and the Transformation of Rhetoric," in Philosophy and Rhetoric 28:1 (1995),
30-44.
"Illness, the Problem of Evil, and the Analogical Structure of Healing: On the Difference
Christianity Makes in Bioethics," Christian Bioethics 1:1 (Spring, 1995), 102-120.
Reprinted in: On Moral Medicine: Theological Perspectives in Medical Ethics, eds. S.
Lammars and A. Verhey (Wm. B. Eerdmans Publishing Co., 1998), pp. 30-41; and in the
3rd edition edited by M. Therese Lysaught, Joseph J. Kotva Jr., Stephen E. Lammers, and
Allen Verhey (2012), pp. 21-28.
Co-authored with H. Tristram Engelhardt, Jr., "Futile Care for the Critically Ill Patient," Current
Opinion in Critical Care (August, 1995), 329-333.
"Expanding the Horizon of Reflection on Health and Disease," Journal of Medicine and
Philosophy 20:5 (October, 1995), 461-473.
"The Sanctity of Life: A Literature Review," in Sanctity of Life and Human Dignity, ed. Kurt
Bayertz (Kluwer Academic Publishers, 1996), pp. 293-310.
“Why Bioethics Needs the Philosophy of Medicine: Some Implications of Reflection on
Concepts of Health and Disease,” Theoretical Medicine 18 (1997), 145-183.
Reprinted in: D. Thomasma (ed.), The Influence of Edmund D. Pellegrino’s Philosophy
of Medicine (Kluwer Academic Publishers, 1997).
“Moral Values and Market Transformations: On the Social Conditions of True Health Care
Reform,” Medical Humanities Review (Spring, 1997), 99-105.
“Embryo Research: On the Ethical Geography of the Debate,” Journal of Medicine and
Philosophy 22:5 (October, 1997), 495-519.
“Bioethics and the Pentecostal Traditions: Christianity as an Alternative Healing System,” in B.
Andrew Lustig (ed.), Theological Developments in Bioethics: 1992-1994 (Kluwer Academic
Publishers, 1997), 123-141.
“Administrative and Organizational Ethics,” HEC Forum: An Interpreofessional Journal on
Health Care Institutions’ Ethical and Legal Issues (December, 1997), 299-309.
Reprinted in: J.A. Worthley (ed.), Organizational Ethics in the Compliance Context
(Health Administration Press, 1999), pp. 23-32. Worthley’s first chapter, which includes
the reprint and commentary, is posted to the web page of the American College of
Healthcare Executives: http://www.ache.org/pubs/oecc1chp.html
“A Radical Rupture in the Paradigm of Modern Medicine: Conflicts of Interest, Fiduciary
10
Obligations, and the Scientific Ideal,” Journal of Medicine and Philosophy 23:1 (February, 1998),
98-122.
“Solidaritaet als moralischer und politischer Begriff: Jenseits der Sackgasse von Liberalismus und
Kommunitarismus,” in Solidaritaet: Begriff und Problem (Suhrkamp Verlag, 1998), pp. 111-145.
Reprinted in English as: “Solidarity as a Moral and Political Concept: Beyond the
Liberal/Communitarian Impasse,” in Solidarity, ed. by K. Bayertz (Kluwer Academic
Publishers, 1999), pp. 57-79.
Co-authored with Robert Sade, “Gene Therapy: Ethical and Social Issues,” The Journal of the
South Carolina Medical Association 94:9 (1998), 406-410.
“Some Reasons to Be Concerned About Genetic Enhancement,” The Journal of the South
Carolina Medical Association 94:9 (1998), 416-418.
“The Scope of Organizational Ethics,” HEC Forum 10:2 (1998), 127-135.
Co-authored with Allan Brett, James Raymond, and Donald Saunders, “An Ethics Discussion
Series for Hospital Administrators,” HEC Forum 10:2 (1998), 177-185.
Co-authored with Robert Gifford, “Understanding, Assessing, and Managing Conflicts of
Interest,” in Surgical Ethics, ed. by L. McCullough, J. Jones, and B. Brody (Oxford University
Press, 1998), pp. 342-366.
“Inalienable Rights in the Moral and Political Philosophy of John Locke: A Reappraisal,” in
Persons and Their Bodies: Rights, Responsibilities, Relationships, ed. by M. Cherry (Kluwer
Academic Publishers, 1999), pp. 177-206.
“Reflections on the Dignity of Guan Zhong: A Comparison of Confucian and Western Liberal
Notions of Suicide,” in Confucian Bioethics, ed. by R. Fan (Kluwer Academic Publishers, 1999),
pp. 103-125.
“Thinking Theologically About Reproductive and Genetic Enhancements: The Challenge,”
Christian Bioethics 5:2 (1999), 154-182.
“Section Editor’s Introduction: Struggling to Understand the Nature of Organizational Ethics,”
HEC Forum 11:4 (1999), 285-287.
“The Case for Managed Care: Reappraising Medical and Socio-Political Ideals,” Journal of
Medicine and Philosophy 24:5 (1999), 415-433.
“The aesthetics of clinical judgment: Exploring the link between diagnostic elegance and
effective resource utilization,” Medicine, Health Care and Philosophy 2 (1999), 141-159.
“Organizational ethics and the medical professional: Reappraising roles and responsibilities,” in
D. Thomasma and J.L. Kissell (eds.), The Health Care Professional as Friend and Healer
(Georgetown University Press, 2000), pp. 148-162
“The two sides of inter-ethics,” HEC Forum 12:3 (2000), 185-190..
11
“The value of comparative analysis in framing the problems of organizational ethics,” HEC
Forum 13:2 (2001).
“Organizational ethics and compliance,” in J. Heller, J. Murphy, and M. Meaney (eds.), Survival
Guide for Compliance Professionals (Aspen Publishers, 2001).
“What is at issue in the debate about concepts of health and disease? Framing the problem of
demarcation for a post-positivist era of medicine,” in L. Nordenfelt (ed.), Health, Science, and
Ordinary Language (Rodopi Press, 2001), pp. 123-169; 215-225.
“Conflicts of interest and medical professionalism: On the need for increased collaboration
between clinicians and administrators,” Journal of the South Carolina Medical Association 97:12
(2001), 513-518.
Coauthored with Robert Best, “Stem cells and the man on the moon: Should we go there from
here?” American Journal of Bioethics 2:1 (2002), 37-39.
Coauthored with Rosemarie Tong, “Setting organizational ethics within a broader social and legal
context,” HEC Forum 14:2 (2002), 77-85.
“The domain of parental discretion in the treatment of neonates: Beyond the impasse between a
sanctity-of-life and quality-of-life ethic,” in J. Tao Lai Po-wah (ed.), Cross-Cultural Perspectives
on the (Im)Possibility of Global Bioethics, (Kluwer Academic Publishers, 2002), 277-298.
“Beyond the question of limits: Institutional guidelines for the appropriate use of critical care,” in
H. T. Engelhardt and M. Cherry (eds.), Allocating Scarce Medical Resources (Georgetown
University Press, 2002), 157-176.
“Engelhardt, the Ik, and the Foundations of Bioethics,” Healthcare Ethics Committee Forum
14:4, 325-334 (December 2002)
“A radical challenge to the traditional conception of medicine: On the need to move beyond
economic factors when considering the ethics of managed care,” in WB Bondeson and J. Jones
(eds.), The Ethics of Managed Care: Professional Integrity and Patient Rights (Dordrecht:
Kluwer Academic Publishers, 2002), 75-91.
“Methodological considerations in the development of a global bioethic,” in P. Hershock, M.
Stepaniants, R. Ames, et al. (eds.), Technology and Cultural Values: On the Edge of the Third
Millennium (Honolulu: University of Hawaii Press, 2003), 117-131.
Systems Theory and the Ethics of Human Enhancement: A Framework for NBIC Convergence,”
in Roco and Montemagno (eds.), The Coevolution of Human Potential and Converging
Technologies, Annals of the New York Academy of Sciences 1013 (2004), 124-149.
The Ethics of Nanotechnology: Vision and Values for a New Generation of Science and
Engineering. In National Academy of Engineering, Emerging Technologies and Ethical Issues in
Engineering. (Washington, DC: National Academies Press, 2004), pp. 29-55.
“ A Heirarchical Architecture for Nanoscale Science and Technology. “ in D. Baird, A.
12
Nordmann, and J. Schummer (eds.), Discovering the Nanoscale (Amsterdam: IOS Scientific
Publishers, 2005), pp. 21-34.
Robert Best and George Khushf, “The stem cell controversy in the United States: Scientific,
philosophical, political, and theological aspects,” in Grenzueberschreitungen/Crossing Borders:
Cultural, Religious, and Political Differences Concerning Stem Cell Research. A Global
Approach. (Munster: Agenda Verlag, 2005), pp. 241-261
“The use of emergent technologies for enhancing human performance: Are we prepared to
address the ethical and policy issues?,” in Public Policy and Practice 4(2), 1-17 (November
2005).
Khushf, G. (2006) “Owning up to our agendas: On the role and limits of science in debates
about embryos and brain death,” The Journal of Law, Medicine, and Ethics 34(1), 58-76.
Khushf, G. (2006) “An ethic for enhancing human performance through integrative
technologies,” in W.S. Bainbridge and M. Roco (Eds.), Managing Nano-Bio-Info-Cogno
Innovations: Converging Technologies in Society (Springer Verlag), 255-278.
Best, R.; Khushf, G., and Wilson, R. (2006) “Introduction: A sympathetic but critical assessment
of nanotechnology initiatives,” Journal of Law, Medicine and Ethics 34(4), 655-657.
Best, R. and Khushf, G. (2006) “The social conditions for nanomedicine: Disruption, systems,
and lock-in,” The Journal of Law, Medicine, and Ethics 34(4), 733-740.
Khushf, G. (2006) “Defensive technologies, human enhancement, and ethical issues,” in
Committee to Review the National Nanotechnology Initiative, National Research Council, A
Matter of Size: Triennial Review of the National Nanotechnology Initiative (Washington, DC:
The National Academies Press), pp. 165-166.
Khushf, G. (2007) “An agenda for future debate on concepts of health and disease,” Medicine,
Health Care and Philosophy 10, pp. 19-27.
Khushf, G. (2007) “The ethics of NBIC convergence,” Journal of Medicine and Philosophy 32,
pp. 185-196.
Khushf, G. (2007) “Open questions in the ethics of convergence,” Journal of Medicine and
Philosophy 32, 299-310.
Khushf, G. (2007) “Upstream ethics in nanomedicine: a call for research,” Nanomedicine 2, pp.
511-521.
Khushf, G. (2007) Importance of a mid-term time horizon for addressing ethical issues integral
to nanobiotechnology. Journal of Long-term Effects of Medical Implants 17(3): 263-269.
Khushf, G. (2008) Stage Two Enhancements. In F. Jotterand (ed.). Emerging Conceptual,
Ethical and Policy Issues in Bionanotechnology (Springer), pp. 203-218.
Khushf, G.; Raymond, J., and Beaman, C. (2008) The Institute of Medicine’s Reports on
Quality and Safety: Paradoxes and Tensions. HEC Forum 20(1): 1-14.
13
Khushf, G. (2008) Health as intra-systemic integrity: Rethinking the foundations of systems
biology and nanomedicine. Perspectives in Biology and Medicine 51(3): 432-449.
Khushf, G. (2009) Open evolution and human agency: The pragmatics of upstream ethics in the
design of artificial life. In M. Bedau and E. Parke (eds.), The Ethics of Protocells: Moral and
Social Implications of Creating Life in the Laboratory. MIT Press. pp. 223-262.
Khushf, G. (2009) Theoretical foundations for an organizational ethic: Developing norms for a
new kind of healthcare. In D. Arnold (ed.), Ethics and the Business of Biomedicine. Cambridge
University Press. pp. 220-248
Khushf, G. (2010) A matter of respect: a defense of the Dead Donor Rule and of a “whole-brain”
criterion for determination of death, Journal of Medicine and Philosophy 35(3): 330-364.
Khushf, G. (2011) The ethics of nano/neuro converegence. In J. Illes and B. Sahakian (eds), The
Oxford Handbook of Neuroethics. Oxford University Press. 467-492.
Khushf, G. (2012) The traditional ritual project, in Solomon, D., Lo, P-C, and Fan, R (eds),
Ritual and the Moral Life, Springer, pp. 209-236.
Fatehi, L., Wolf, S. and 21 co-authors of working group, including Khushf, G. (2012)
Recommendations for Nanomedicine Human Subjects Research Oversight: An Evolutionary
Approach for an Emerging Field, Journal of Law, Medicine, and Ethics 40 (4): 716-750.
Khushf, G. and Siegel, R. (2012) What is Unique about Nanomedicine? The Significance of the
Mesoscale, Journal of Law, Medicine, and Ethics 40(4): 780-794.
Khushf, G. (2013) A framework for understanding medical epistemologies, Journal of Medicine
and Philosophy 38: 461-486.
Khushf, G. (2013) Beware of mereologists bearing gifts: Prolegomena to a medical metaphysics,
Theoretical Medicine and Bioethics 34(5): 385-408.
Khushf, G. (2015) The ethics of convergence for enhancement of cognition, in Bainbridge, W.S.
and Roco, M. (eds), Handbook of Science and Technology Convergence, Springer, 2015.
Khushf, G. (2015) A transcendental argument for agreement as the sole sufficient basis of a
philosophical ethic, in Rasmussen, L., Iltis, A.S., and Cherry, M. (eds), At the Foundations of
Bioethics and Biopolitics: Critical Essays on the Thought of H. Tristram Engelhardt, Jr.,
Springer, 2015, pp. 87-144.
Selected Reviews, Abstracts, and Short Essays
"Proportional Coinsurance: An Alternative to Managed Competition," Health Affairs (Winter,
1993), 263-264.
Review of Religion in Aging and Health: Theoretical Foundations and Methodological
Frontiers, ed. Jeffrey Levin, The Journal of Nervous and Mental Disease, Vol. 183, No. 11
14
(November 1995), 723-724.
Review of Foundations of Bioethics, by. H. Tristram Engelhardt, The New England Journal of
Medicine, Vol. 335:2 (July 11, 1996), 141-142.
“Nursing Ethics at the Juncture of Two Kinds of Care,” The South Carolina Nurse (July, August,
September, 1997), 3-4.
Review of Christian Hermeneutics: Paul Ricoeur and the Refiguring of Theology, by James
Fodor, for International Journal of the Philosophy of Religion (1997), 126-128.
Review of What is a Disease?, ed. James Humber and Robert Almeder, Doody’s Review Service,
http://www1.doody.com, 1997.
Review of Bioethics in a Liberal Society, by Max Charlesworth, International Studies in
Philosophy 30:2 (1998), 124-125.
Co-authored with Rebecca Pentz, “A Progress Report on the First ASBH Annual Meeting,”
ASBH Exchange 1:2 (Spring 1998), pp. 3,4.
“A Disease Concept for a Post-Flexnerian Medical Education: Reconfiguring the Relation
Between the Basic Sciences, Clinical Experience, and the Humanities,” European Philosophy of
Medicine and Health Care 6:1 (1998), 80-81.
Review of International Kierkegaard Commentary: Either/Or, Parts I and II, by Robert Perkins
(ed.), for International Journal for the Philosophy of Religion (1999), 122-125.
Review of Bioethics Internet Project for American Philosophical Association Newsletter on
Philosophy and Computers (Spring 2000), 170-171.
Best, R., Khushf, G. (2007) Dissecting the disruptive nature of nanomedicine. Nanomedicine:
Nanotechnology, Biology and Medicine 2(4): 303.
Khushf, G., Murphy, C., and Wang, Q. (2007) A taxonomy of ethical issues integral to
nanobiotechnology. International Journal of Medical Implants and Devices 2: 18.
Khushf,G. (2011) Abstract: Ethics as meta-engineering: a novel research design for anticipatory
governance in tissue biofabrication, International Journal of Medical Implants and Devices 5(1):
9.
Best, R. G., Khushf, G. (2012, January). The Next Step in Clinical Cytogenetics: Moving Beyond
Empirical Rules. In Cytogenetic and Genome Research Vol. 136, No. 4, pp. 342.
Selected Presentations and Participation at Conferences
"The Death and Resurrection of Reason," presented at a colloquium sponsored jointly by the
University of Tübingen and the Institut zur Erforschung des Urchristentums, Tübingen, Germany,
1988.
15
Participated by invitation in the conference "Juden und Christen heute," conducted by the Institut
für ökumenische Forschung and directed by Hans Küng, 1989.
"The Role of 'the Letter' in the Development of Occidental History and in Christianity," presented
at a Stanford Centennial Conference titled "Writing/Ecriture/Schrift," Stanford University, Palo
Alto, California, February, 1991.
"The Transition from Culture Protestantism to Neo-Orthodoxy," presented at The American
Academy of Religion, Southwest Regional Meeting, Dallas, Texas, March, 1991.
"Futility and Rights: Different Conceptualizations and their Relevance for the Developing
World," presented at "Developing the Philippine Literature," sponsored by the International
Federation of Catholic Universities, Houston, Texas, August, 1991.
"On the Difference Between Revelation and Revolution," presented at the American Academy of
Religion, Southwest Regional Meeting, Dallas, Texas, March, 1992.
"Between Logocentrism and Grammatology," presented at the American Philosophical
Association, Central Division Meeting, Louisville, Kentucky, April, 1992. Professor John
McCumber was the respondent.
"The Critical Role of Theology in Relation to Science: A Word on Behalf of Bellarmine,"
presented at a Department of Religious Studies Public Colloquium, Rice University, Houston,
Texas, May 7, 1993.
"The Circle of Explanation: Putting Cases in Their Cultural Context," presented at "Bioethics in
the Philippines: Readings and Cases," sponsored by the International Federation of Catholic
Universities, Houston, Texas, May 19, 1993.
Participated by invitation in "Liberty, Ethics, Community and Environmental Changes,"
conducted by the Foundation for Research on Economics and the Environment and sponsored by
The Liberty Fund, Island Park, Idaho, August 2-8, 1993.
Panelist with M. David Low and James Phillips on "Public Responsibility and Health Care
Reform," at the conference "Health Care Reform: Religious Fidelity, Professional Integrity, and
Public Responsibility," sponsored by the Institute of Religion, Houston, Texas, February 2, 1994.
Participated by invitation in "Authority, Tradition, and Liberty," sponsored by the Liberty Fund,
Houston, Texas, February 24-27, 1994.
Participated by invitation in "Toward a Free and Virtuous Society," conducted by the Acton
Institute, San Juan Capistrano, California, March 3-6, 1994.
"The Complementarity of the Analogia Entis and the Analogia Fidei," presented at a section on
science and religion, The American Academy of Religion, Southwest Regional Meeting, Dallas,
Texas, March 19, 1994.
"Enhancing Price Sensitivity in the Health Care Sector," presented at the Southwestern Social
Sciences Association, San Antonio, Texas, April 1, 1994.
16
"Healing and/as Theodicy," presented at a session of "Recovering the Traditions II: Religious
Perspectives in Medical Ethics," a conference conducted by The Institute of Religion, Houston,
Texas, June 15, 1994.
Participated by invitation in "The Religious Foundations of Liberty," conducted by the Acton
Institute and sponsored by Liberty Fund, Grand Rapids, Michigan, June 16-19, 1994.
"Theology and Suffering," presented at a summer Clinical Pastoral Education (CPE) Conference
on Dying and Choosing, conducted by the Institute of Religion, Houston, Texas, June 29, 1994.
"Individuality, Community, and Solidarity," presented at a session of "Solidarity," a conference
conducted by the Center for Interdisciplinary Research, Bielefeld, Germany, October 13, 1994.
Participated by invitation in "Honesty and Responsibility in the Practice of Medicine," conducted
by Baruch Brody and sponsored by the Liberty Fund, Houston, Texas, November 10-13, 1994.
"Triage and the Integrity of Medicine," presented at Fairfield University, Fairfield, Connecticut,
February 2, 1995.
"How the Sign of Contradiction Overcomes Despair: Reflections on Christian Healing,"
presented at a joint session of the Kierkegaard Society and the Southwest Commission on
Religion, Dallas, Texas, March 11, 1995.
"Bioethics and the Sanctity of Life," presented as the Rockwell Lecture at the Theology and
Practical Issues Dialogue, University of Houston, Houston, Texas, April 4, 1995.
Participated by invitation in "Community, Society, and the State," sponsored by Liberty Fund,
Houston, Texas, July 20-22, 1995.
Selected as a participant (a competitive application process), Southwest Regional Teaching
Workshop, sponsored by Lilly Foundation, National Endowment for the Humanities, and the
American Academy of Religion, August 7-13 and October 13-15, 1995.
"Engelhardt, the Ik, and the Foundations of Bioethics," delivered at the Plenary Panel of the
conference "Ethics, Medicine, and Health Care," Youngstown University, Youngstown, Ohio,
Sept. 29-Oct. 1, 1995.
"Inalienability and John Locke," delivered to the GINT Political Theory Symposium, University
of South Carolina, October 27, 1995.
Organized the session on "The Ethics of Care" for the Annual Retreat of the South Carolina
Medical Association Ethics Committee, and presented "Phenomenological Approaches to the
Ethics of Care," Hilton Head, South Carolina, February 9-11, 1996.
"Bioethics and Religious Pluralism: Making a Place for Difference," delivered at the annual
meeting of the Southwest Commission on Religious Studies, Dallas, Texas, March 16, 1996.
"Crafting a Humane Medicine in the Context of Managed Care: Opportunities and Pitfalls"
(invited speaker), delivered at the conference "Controversies in Bioethics," sponsored by the
Department of Medical Humanities, East Carolina University School of Medicine and EAHEC,
Greenville, North Carolina, March 18, 1996.
17
"Market-Based Health Care Reform: The Method of Proportional Coinsurance," delivered at the
Institute of Health and Human Values, Medical University of South Carolina, Charleston, South
Carolina, April 9, 1996.
"Medical Ethics of Managed Care," delivered at the conference "Altering Physician Behavior,"
sponsored by the Swedish Medical Center and the Puget Sound Spine Interest Group, Seattle,
Washington, April 19, 1996.
"Ethical Considerations for the Geriatric Patient," delivered at the Grand Rounds of the Division
of Geriatrics, Department of Medicine, University of South Carolina, May 8, 1996.
"Why Bioethics Needs the Philosophy of Medicine," delivered at the Eighth Annual Bioethics
Summer Retreat, Copper Mountain, Colorado, June 21, 1996.
"Ethical Issues in Long Term Care," presented as a part of a seminar conducted by the South
Carolina Health Care Association and endorsed by the Governor's Office Division on Aging,
Columbia, South Carolina, June 27, 1996.
"Patient Rights and Organizational Ethics -- Meeting the JCAHO Standards," delivered at a
seminar of the South Carolina Chapter of the Healthcare Financial Management Association,
Columbia, South Carolina, July 17, 1996.
"Principles of Ethical Decision-Making," presented a meeting of HomeCare Resources, an
affiliate of Baptist Healthcare System of South Carolina, Columbia, South Carolina, September 8,
1996.
"Physician Assisted Suicide," delivered a Panel Session of the Ninth Annual Health Law
Seminar, conducted by the Continuing Legal Education Division of the South Carolina Bar,
September 20, 1996.
"Integrating Entrepreneurial and Professional Aspects of Medicine," delivered at a conference on
Money and Medicine, conducted by the Center for Bioethics, Columbia, South Carolina, October
5, 1996.
"The Ethical Geography of Futility Assessment in Peri/Neonatology: Value Desiderata in
'Medical Indication,'" delivered at the conference "Neue Wege in der Behandlung Fruhgeborener
- Perinatologie im Spannungsfeld zwischen Medizin, Evolutionabiologie, Psychologie and
Ethik," conducted by faculty at the Max-Planck-Gesellschaft, Andeche at the Werner Reimers
Stiftung, Bad Homburg, Germany, October 16, 1996.
With R.E. McKeown and D.L. Richter, “Decision Making in Bioethics and Theories of Health
Behavior: Invitation to Dialogue,” delivered at the American Public Health Association, New
York, NY, November 20, 1996.
'Medical Ethical Issues on the Horizon,' delivered at the Annual Medical Staff Meeting, Springs
Memorial Hospital, Lancaster, South Carolina, November 26, 1996.
'Developing an Ethics Committee,' delivered at Loris Community Hospital, Loris, South Carolina,
January 31, 1997.
18
Panel Participant, Bioethics in South Carolina, South Carolina Society for Philosophy, Beufort,
South Carolina, February 22, 1997.
'Embryo Research: The Ethical Geography of the Debate,' delivered at the Institute for Human
Values in Health Care, Medical University of South Carolina, Charleston, South Carolina, March
25, 1997.
‘An Algorithm for Managing Conflicts of Interest,’ delivered at the Ninth Annual Bioethics
Summer Retreat, Hilton Head, South Carolina, June 12, 1997.
‘Ethical Issues in Managed Care,’ delivered at the Summer School of Gerontology, Rock Hill,
South Carolina, August 4, 1997.
‘Beyond the Question of Limits: Institutional Guidelines for the Appropriate Use of Critical
Care,’ delivered at the conference ‘Limiting Access to Medical Treatment,’ Principality of
Liechtenstein, August 29, 1997.
‘Grant Writing in Bioethics and the Medical Humanities,’ delivered presentation and organized
panel for a preconference workshop, joint meeting of the American Bioethics Association,
Society for Bioethics Consultation, and Society for Health and Human Values, Baltimore,
Maryland, November 5, 1997.
‘Administrative and Organizational Ethics,’ delivered at the ‘Health Management Book Session,’
joint meeting of the American Bioethics Association, Society for Bioethics Consultation, and
Society for Health and Human Values, Baltimore, Maryland, November 8, 1997.
‘Health and/as Healing,’ presentation at the Comparative Studies in Religion Section, Annual
Meeting of the American Academy of Religion, San Francisco, California, November 22, 1997.
‘Human Gene Therapy: The Ethical Geography of the Debate,’ delivered at the Annual Retreat of
the South Carolina Medical Association Ethics Committee, Hilton Head, South Carolina,
February 7, 1998.
‘Beyond the Question of Limits: Institutional Guidelines for the Appropriate Use of Critical Care
(revised version),’ delivered at the second conference on Limiting Access to Medical Treatment,
Houston, Texas, February 10, 1998.
Panel response (on embryo research and genetics) to Lee Silver, delivered at University of South
Carolina science studies meeting ‘Remaking Eden: Cloning and Beyond in a Brave New World,’
March 3, 1997.
‘Is Medicine Value-Neutral? A Critique of Medical Foundationalism,’ delivered at the Society
for Health and Human Values spring meeting, Greenville, North Carolina, March 14, 1998.
‘Concepts of Health and Disease and Clinical Ethics,’ delivered at the Medical Humanities
Faculty Lunch, University of South Carolina, Columbia, SC, April 15, 1998.
‘On the Difference Christianity Makes in Bioethics: Illness, the Problem of Evil, and the
Analogical Structure of Healing,’ delivered at ‘Recovering the Traditions: Religious Perspectives
19
in Medical Ethics,’ Fort Lauderdale, Florida, April 28, 1998.
“Reforming Managed Care: The Method of Proportional Coinsurance,” delivered at the Tenth
Annual Bioethics Summer Retreat, Brewster, MA, June 18, 1998.
“Ethical Considerations in Withholding Artificial Nutrition and Hydration,” delivered at the
Zentrum fuer Ethik in der Medizin, St. Markus-Krankenhaus, Frankfurt/M, Germany, August 19,
1998.
“A Disease Concept for a Post-Flexnerian Medical Education: Reconfiguring the Relation
Between the Basic Sciences, Clinical Experience, and the Humanities,” delivered at the European
Society for the Philosophy of Medicine and Healthcare, Marburg, Germany, August 20, 1998.
“Organizational Ethics and the Medical Professional: Reappraising Roles and Responsibilities,”
delivered as a Plenary Session of the conference “Ethical Dilemmas in Health Care in the 21st
Century,” Des Moines, Iowa, October 30, 1998.
“Beyond the Question of Limits: Institutional Guidelines for the Appropriate Use of Critical
Care” (third revision), and response essay to Paul Schotsmans, delivered at the third conference
on Limiting Access to Medical Care, Houston, Texas, October 25-26.
Commentator on Gerald McKenny’s To Relieve the Human Condition: Bioethics, Technology,
and the Body, delivered at the American Society for Bioethics and the Humanities annual
meeting, Houston, Texas, November 19, 1998.
“Philosophy of Medicine/Theoretical Medicine as a Discipline,” panel session at the American
Society for Bioethics and the Humanities annual meeting, Houston, Texas, November 20, 1998.
“A Schema of Health Concepts,” delivered at the Retreat of the Medical Ethics Committee of the
South Carolina Medical Association, Hilton Head, South Carolina, February 6, 1999.
“Can Bioethics Move Beyond Rationalizing the Interests of Science? Reflections on Reprogentic
Therapy and Enhancement,” delivered at the Department of Philosophy, Clemson University,
February 11, 1999.
With Mark Meaney, “The Role of Ethics in a Compliance Program,”delivered at the Annual
Southeastern Health Care Compliance Institute, Atlanta, Georgia, April 29-30, 1999.
“Fostering Ethics Beyond the Clinic Door: The Impact of Organizational Ethics,” delivered at the
Sixth Annual Conference of the Health Care Ethics Consortium of Georgia, Atlanta, Georgia,
May 3, 1999.
“Beyond the Question of Limits: Institutional Guidelines for the Appropriate Use of Critical
Care,” presented at the working group “Limiting Access to Critical Care,” sponsored by the
International Federation of Catholic Universities, Barberstown Castle, Straffan, County Kildare,
Ireland, May 12-17, 1999.
“The Domain of Parental Discretion in Treatment of Neonates: Beyond the Impasse Between the
Sanctity and Quality of Life Ethics,” presented at “International Conference on Bioethics -Individual, Community, and Society: Bioethics for the Third Millennium,” sponsored by the
20
Centre for Comparative Public Management and Social Policy and the Ethics in Contemporary
China Research Group, City University of Hong Kong, Hong Kong, China, May 25-28, 1999.
“Is Medicine in the Midst of a Paradigm Shift?,” presented at the Eleventh Annual Bioethics
Summer Retreat, Hot Springs, Virginia, May 24-29, 1999.
“Organizational Ethics,” presented with Rosemarie Tong at the conference on Organizational
Ethics, sponsored by the Bioethics Resource Group, Charlotte, NC, July 21, 1999.
“The Eclipse of Vitalism in Medicine,” presented for the History of Medicine Society, sponsored
by Baylor College of Medicine and the Texas Medical Community, Houston, Texas, September
14, 1999.
“Theoretical Foundations for Organizational Ethics,” presented for the Philosophy Affinity Group
at the annual meeting of the American Society for Bioethics and Humanities, Philadelphia,
Pennsylvania, October 28, 1999.
“Inter-Ethics: Developing Norms for a New Paradigm of Healthcare,” presented in a workshop on
organizational ethics at the annual meeting of the American Society for Bioethics and
Humanities, Philadelphia, Pennsylvania, October 31, 1999; I was also the moderator for that
session.
“Administrative and Organizational Ethics,” presented at “Taking the Next Steps: Second Annual
Fall Seminar and Workshop, Health Care Ethics in South Carolina,” Embassy Suites Hotel,
Columbia, SC, September 24-25.
“Methodological Considerations in the Development of a Global Bioethic,” presented at the
session “The Philosophy of Biomedical Technology and Bioethics,” Eighth East-West
Philosophers’ Conference: Technology and Human Values on the Edge of the Third Millennium,
sponsored by the University of Hawaii and East-West Center, Honolulu, Hawaii, January 18,
2000.
“Organizational Ethics: The Issues and Agenda,” presented at the annual retreat of the Medical
Ethics Committee of the South Carolina Medical Association, Hilton Head, South Carolina,
February 4-6, 2000; I was also the organizer of this retreat on organizational ethics.
“Organizational Ethics, Part I: Inter-Ethics: Developing a Form of Ethical Reflection that is
Responsive to New Realities of Health Care,”presented at the Health Care Compliance
Association’s Sotheastern Compliance Institute, Orlando, Florida, June 22, 2000.
“Organizational Ethics, Part II: The Limits of Compliance: Developing a Self-Critical Stance as a
Component of Professionalism,” presented at the Health Care Compliance Association’s
Sotheastern Compliance Institute, Orlando, Florida, June 22, 2000.
“Organizational Ethics and Compliance,”presented with John Moskop at the 12th Annual
Summer Bioethics Retreat, at the Asilomar Conference Center, Asilomar, California, June 24,
2000.
“What’s God Got to Do With It? Medical Education, Spirituality and the Physician-Patient
Relationship,” presented with Janet Fleetwood, Cynthia Cohen and John Moskop at the 12th
Annual Summer Bioethics Retreat, at the Asilomar Conference Center, Asilomar, California,
21
June 24, 2000.
“Health Care Priorities and the Reprogenetic Revolution: On Reduction, Holism, and the
Molecular Biological Turn,” presented at the Second International Conference of Bioethics,
Graduate Institute of Philosophy, National Central University, Chungli, Taiwan, June 30, 2000.
“A Schema of Health Concepts: On the Notions of Health and Disease Implicit in Diverse Health
Agencies and Institutions,” presented at the Centre for Public Policy Research, King’s College
London, July 4, 2000.
“Inter-ethics: developing norms for a new paradigm of healthcare,” delivered at the Second
World Congress of Philosophy and Medicine, Krakow, Poland, August 24, 2000.
Respondent to John Stone, “Deliberation and difference in bioethics,” delivered at the Philosophy
Affinity Group, American Society for Bioethics and Humanities, Salt Lake City, UT, October 27,
2000.
“Developing theoretical medicine as a discipline,” delivered at the Theoretical
Medicine/Philosophy of Medicine Affinity Group, American Society for Bioethics and
Humanities, Salt Lake City, UT, October 27, 2000.
“Panel presenter, “Faith and reason: Christian bioethics in a broken world,” at American Society
for Bioethics and Humanities, Salt Lake City, UT, October 28, 2000.
“Organizational ethics and compliance,” delivered at the Organizational Ethics Affinity Group,
American Society for Bioethics and Humanities, Salt Lake City, UT, October 28, 2000.
Ethics Grand Rounds on the topic of organizational ethics, Hilton Head Hospital, Hilton Head,
SC, January 16, 2001.
“Conflicts of interest and conflicts of obligation,” delivered at the Ethics Retreat of the South
Carolina Medical Association, Hilton Head, SC, February 2, 2001.
With Sharda Pai, Neonatal ethics for Pediatric Grand Rounds, Palmetto Richland Hospital, March
9, 2001.
“Illness and the problem of evil,” delivered at the Anglican Society, Columbia, SC, March 13,
2001.
“Following the rules: Organizational ethics and compliance,” delivered at the conference
“Healthcare Ethics in South Carolina: A Sense of Direction,” Furman University, Greenville, SC,
March 31, 2001.
Panelist, “Forum on Research Ethics,” sponsored by School of Law and Office of Research
Compliance, University of South Carolina, April 3, 2001.
“Managed care as a radical challenge to traditional medical norms: A response to Baruch Brody
and Robert Sade,” delivered at the conference “The Ethics of Managed Care: Professional
Integrity and Patient Rights,” Fairmont Hotel, Kansas, City, Missouri, May 4, 2001.
“Organizational Ethics,” presented at the Health Care Compliance Association’s 3rd Annual
Southeastern Compliance Institute, Myrtle Beach, South Carolina, May 16, 2001.
22
“The Health Concepts Schema: A Framework for Clarifying the Notions of Health and Disease
Implicit in Diverse Approaches to Health Care,” presented by invitation at the International
Academy of Law and Mental Health, Montreal, Canada, July 1,2001.
Together with Stephen Williams, JD, “Organizational and Biomedical Ethics in Hospice and End
of Life Care,” presented as the morning session for the Carolinas Center for Hospice and End of
Life Care, Charlotte, North Carolina, July 20, 2001.
“Access to Medical Care,” presented as the opening session of the South Carolina Medical
Association’s Ethics Retreat, Hilton Head, South Carolina, February 15, 2002.
“Hans Driesch and the State of the Vitalism Debate,” presentation at the Joint Meeting of the
North and South Carolina Philosopy Association, Charleston, SC, March 2, 2002.
“Ethical issues in community based research,” presented at the Center for Health Promotion and
Risk Reduction in Special Populations, USC College of Nursing, March 18, 2002.
“The Ethics of Nano-technology,” presented in the lecture series on nanotechnology, Physical
Sciences Building, USC, May 9, 2002.
“Organizational Ethics and the Medical Professional,” and “Administrative and Organizational
Ethics: What has (and hasn’t) worked in the United States,” plenary sessions at the conference
“Ethik der Institutionen, Beispiel Krankenhaus: Zwischen Leitbild und Organisationsethik,”
Frankfurt, Germany, June 21-23, 2002.
Organizer and moderator of the session, “Dead, Dormant or Developing: What is the State of the
Philosophy of Medicine Today? Presented by Arthur Caplan; response by Mark Cherry” at the
American Society for Bioethics and Humanities, Baltimore, October 26, 2002.
“The Metaphysical Foundations of Natural Law,” plenary presentation at the conference on the
Future of Natural Law: The Death of Metaphysics, the Death of Culture, St. Edwards University,
Austin, Texas, November 9, 2002.
“Assumptions involved in assessing alternative medicine,” presented at the conference
“Alternative Medicine: Fact or Fantasy,” Susquehanna University, Selinsgove, Pennsylvania,
March 7, 2003.
“Systems theory and the ethics of enhancement: A framework for NBIC convergence,” delivered
at the USC nano-conference, March 22, 2003.
Panel presenter for the session “Ethical, Legal, Social Issues in Genetics,” delivered at SCETV in
Spartanburg, South Carolina, April 17, 2003.
“A hierarchical architecture for nano-scale science and technology: taking stock of the claims
about science made by advocates of NBIC convergence,” Presented at the conference,
Discovering the Nanoscale, Darmstadt, Germany.
23
With Robert Best, “The ethics and culture of human enhancement,” presented at the conference,
Discovering the Nanoscale, Darmstadt, Germany.
“The ethics of nanotechnology,” delivered at the American Academy of Engineering,
Washington, DC, October 15, 2003.
“Ethics and the framing problem in nano/bio convergence,” delivered at the session
“Nanotechnology: Safety, Ethics and Regulation,” NanoBioconvergence, Palo Alto, California,
January 28, 2004
“The ethics of nanomedicine,” delivered at the annual retreat of the Ethics Committee of the
South Carolina Medical Association, Hilton Head Island, SC, February 7, 2004.
“The ethics of NBIC convergence for human enhancement: On the task of framing a responsible
future,” NBIC Convergence 2004: Converging Technologies for Improving Human Performance,
New York Marriott Financial Center, New York, February 26, 2004.
“Organizational ethics,” presented at the South Carolina Ethics Network Annual Meeting,
Embassy Suites, Columbia, SC, March 5, 2004.
“Owning up to our agendas: why there are no unbiased accounts of embryo research and brain
death,” delivered at the Pitts Memorial Conference on Decision Making at the Beginning and End
of Life, Medical University of South Carolina, Charleston, SC, September 2004.
Guest speaker on the ethics of cosmetic surgery for Chicago public radio talk show, September 7,
2004.
“Neuroenhancements,” delivered at the Panel on Ethical, Legal and Societal Implications of
Advances in Neuroscience, Cognitive Science, and Neurotechnologies, American Society for
Bioethics and the Humanities, Philadelphia, PA, October 30, 2004
“Core issues in theoretical medicine,” delivered at the Affinity Group Meeting on Theoretical
Medicine, American Society for Bioethics and the Humanities, Philadelphia, PA, October 30,
2004.
“Three conditions for realizing the promise of nanomedicine,” presented at the International
Association of Nanotechnology, Oakland Convention Center, Oakland, San Francisco, November
11, 2004.
“Research directions in bioethics,” delivered at the Annual Ethics Retreat of the South Carolina
Medical Association Ethics Committee, Hilton Head, SC, February 4-6, 2004.
Panel presentation on NBIC Convergence at “Nano Ethics: An International and Interdisciplinary
Conference at the University of South Carolina,” Columbia, SC, March 3, 2005
“Nanotechnology and the polarization paradaox,” delivered at “Nano Ethics: An International and
Interdisciplinary Conference at the University of South Carolina,” Columbia, SC, March 4, 2005
“Nanotechnology and ethical issues of human enhancement” invited presentation for the
Workshop on Standards for the Responsible Development of Nanotechnology, National Research
24
Council Committee to Review the National Nanotechnology Initiative, National Academy of
Sciences, Washington, DC, March 24-25, 2005.
“Ethical and social implications of nanotechnology,” invited open campus presentation at Regis
University, Denver, Colorado, April 2, 2005.
“Converging Technologies for Enhancing Human Performance,” delivered at the Ethics Ground
Rounds of the UT Southwestern Medical School, Dallas, Texas, April 12, 2005
“Ethics in emerging technologies,” delivered at the MRSEC Director’s Meeting, University of
Southern Mississippi, April 14-15, 2005. (This is an annual meeting for Directors of National
Science Foundation Materials Research Science and Engineering Centers.)
“Nanomedicine and aging research,” a public discussion sponsored by the Sage Crossroads
Alliance on Aging Research, University of California San Francisco (UCSF), San Francisco, CA,
April 21, 2005.
“The beautiful experiment,” delivered at “Imaging NanoSpace” Bildwelten der Nanoforschung,
Zentrum fuer Interdisziplinaere Forschung, Universitaet Bielefeld, Germany, May 12, 2005.
“Why nanotechnology forces us to change how we approach ethics and technology policy,”
delivered at the First International Nanotechnology Conference on Communication and
Cooperation (INC1), June 3, 2005
“Why bionanotechnology forces us to rethink how we approach ethical issues integral to
scientific research,” delivered at the PACE-Pas science coordination workshop on artificial life,
held at Los Alamos National Laboratory, Los Alamos, NM, July 21, 2005.
“A strong normativist theory of health,” (invited presentation for health concepts session in honor
of Lennart, Nordenfelt, the outgoing president of the ESPMH) delivered on August 26, 2005 at
“Ethics and philosophy of emerging medical technologies,” the XIXth European Conference on
Philosophy of Medicine and Health Care: A Joint EACME and ESPMH Conference, Barcelona,
Spain
September 30, 2005 “Science and Ethics at the Boundaries of Life” (presentation on nano/bio)
for the Richland County Public Library events surrounding the National Library of Medicine
exhibit on Frankenstein
“Ethical issues integral to nanobiotechnological research related to the human machine interface,”
presented at “Making the human-machine interface specific: Ethical, legal, and social aspects of
implants and neurobionics,” a joint workshop of the EU NanoBio-RAISE and Nano-2-Life
working groups, Marburg, Germany, January 20, 2006
“A conceptual framework for organizational ethics: developing norms for a new paradigm of
health care,” presented at the conference “Ethics and the business of biomedicine,” University of
Tennessee, Knoxville, TN, April 7, 2006.
“Nanobiotechnology: Preparing for the likely public and policy issues,” delivered at Bio 2006
Chicago Annual International Convention, Chicago, IL, April 11, 2006
25
Invited participant, “Tolerance and Truth as the Axes of Religious Liberty,” Conference director:
David Walsh, Catholic University of America, a Liberty Fund Colloquium held April 27-30, 2006
at Hotel George, Washington, DC.
“Evaluating a formalism for integration of mathematical models across scales in systems
biology,” presented at the NIRT nano-STS retreat, Pines Country Inn, Pisgah Forest, North
Carolina, May 19-21, 2006
“Developing upstream ethics initiatives in nanotechnology,” presented at the Center for
Bioethics, University of Pennsylvania, Philadelphia, PA, June 6, 2006
“The ethics of nanomedicine,” presented at the British Columbia Cancer Agency, Vancouver,
BC, as part of the Southeastern US Omics-Nano Mission to British Columbia and Alberta, an
Enhanced Representative Initiative (ERI), sponsored by the Canadian Consulate General, The
National Research Council of Canada, and the Western Economic Diversification Canada, June
4-9, 2006.
“Ritual in science and medicine,” presented at the International Symposium on Traditional Ritual
and Contemporary Society, Hong Kong Baptist University, Hong Kong, July 5, 2006.
“Nanoethics: How novel are the ethical issues?,” presented at the American Society for Bioethics
and the Humanities, Denver, Colorado, October 29, 2006
“Integrating ethics as a vital component of interdisciplinary nanobiotechnological research,”
presented at Ohio State University, Columbus, OH, October 10, 2006
“Will enhancements enhance our future,” presented at “Eugenics and Emerging Technologies,”
organized by the Center on Nanotechnology and Society, Chicago-Kent College of Law and
Illinois Institute of Technology, held at the Washington Press Club, Washington, DC, November
10, 2006.
“Upstream ethics in Nanobiotechnology,” presented at the International Institute for
Nanotechnology, Northwestern University, January 18, 2007.
presentations on development of ethics research for NSEC at working group meetings of
Nanoscale Science and Engineering Center, Ohio State University, Columbus, OH, January 2324, 2007.
Best, R., Khushf, G., Gregg, A., and Lopez-deFede, A. Interferon based testing for tuberculosis
as a disruptive innovation, poster presentation at Rethinking the Epidemiology of Tuberculosis
Infection – the First Global Symposium on Interferon-Gamma Assays, held at the Sheraton
Vancouver Wall Centre Hotel, Vancouver, BC Canada, February 21-22, 2007.
“Complexity, systems and control in nanobiotechnology” for the Ethical Implications and Issues
Panel, for the Societal Implications of Nanotechnology: 2007 Principal Investigators Meeting,
National Science Foundation, Arlington, VA, March 15-16, 2007 (invited).
Team leader for Nanotechnology at the workshop Research Ethics Education: Beyond RCR
Training – Building the research ethics education community, Sheraton Raleigh Capital Center,
Raleigh, North Carolina, April 12-14. (Work to develop an ethics module on nanotechnology
that will be included on the online LANGUIRE research ethics curriculum training program).
26
“Stage 2 Enhancements,” presented at Dartmouth NSF Workshop, Nanotechnology and Human
Enhancement, Dartmouth University, April 14, 2007.
Khushf, G. Murphy, C. and Wang, Q. A taxonomy of the ethical issues integral to
nanobiotechnology, presented at The Fourth International Conference on Ethical Issues in
Biomedical Engineering, Suny Downstate Medical Center/ Polytechnic University, New York,
April 20-22, 2007.
“Developing notions of control in nanobiotechnology,” presented at the workshop on Engineering
Theory at the Center for Interdisciplinary Research, Bielefeld University, Germany, May 3, 2007.
“Upstream ethics in nanomedicine: A case study on the elements of a translational research
ethic,” presented at UT Southwestern Medical School, Dallas, Texas, August 2007.
“Health as intra-systemic integrity,” presented at the Boston Colloquium for Philosophy of
Science, Boston, MA, September 24, 2007.
Dix, D., Khushf, G., Best, R. “A multi-level hierarchical systems model of neural tube closure,”
presented at the Fifth International Neural Tube Defects Conference, September 27, 2007.
Presentation on ethical issues integral to nanobiotechnology to the Colloquium on Ethical
Leadership, Office of Enrollment Services and Undergraduate Education, Ohio State University,
October 12, 2007.
“Responsible scientific conduct in an era of nanotechnology,” presented at the 2007 International
Institute of Nanotechnology Symposium, Northwestern University, Evanston, IL, October 24,
2007.
“Why nanoethics needs a midterm time horizon,” presented in the morning to a molecular
biology class at Auburn University and at noon to a course on ethical issues integral to
nanotechnology and telecast to Tuskegee University and Auburn UN-Montgomery, October 31,
2007.
“Ethical issues integral to developing human/machine interfaces,” presented at an ethics and
policy seminar conducted by Rosemarie Tong, University of North Carolina at Charlottee, April
2, 2008.
Panelist, “Ethics in Nanotechnology” roundtable at the Ethics in Emerging Technologies
symposium, April 11-12, 2008, University of North Carolina, Charlotte.
“Integrating ethics with neural implant research,” delivered at the Gordon Research Conference
“Governing emerging technologies,” Big Sky, Montana, August 17-22, 2008.
“Ethical implications of today’s decisions for tomorrow,” delivered at the 2008 Executive
Retreat, Leadership for the Future, Lutheran Services of America, Charleston, SC, November 9,
2008.
27
“Nanoethics: bioethics for emerging technologies,” presented at Governing Nanobiotechnology:
Reinventing Oversight in the 21st Century, University of Minnesota, Minneapolis, MN, April 15,
2010
“A novel research design for an upstream ethics initiative in tissue bioengineering,” presented at
the Second Annual Conference of the Society for the Study of Nanoscience and Emerging
Technologies (S.NET), Technische Universitaet Darmstadt, Germany, October 2, 2010
“Governing nanomedicine: A case study in translational research ethics,” presented at University
of North Carolina, Charlotte, October 14, 2010
“Nanomedicine research ethics: beyond research participants to the community,” presented at the
12th Annual Meeting of the American Society for Bioethics and the Humanities (ASBH), Hilton
San Diego Bayfront, San Diego, California, October 22, 2010
“Death as a bridgework concept,” presented as the Thomas Jack Lynch Lecture, Department of
Philosophy, Wake Forest University, February 10, 2011.
“Diversity in Health Care Settings: Why should it matter?” presented At the Clinical Ethics
Committee Lunch and Learn, Wake Forest University Baptist Medical Center, February 11, 2011.
“Ethics as meta-engineering: a novel research design for anticipatory governance in tissue
biofabrication,” Invited Speaker for Sixth International Conference on Ethical Issues in
Biomedical Engineering, New York Academy of Sciences, held at Polytechnic Institute of NYU,
Brooklyn, NY, April 1-2, 2011.
“Death as a Bridgework Concept,” invited speaker for the conference on Dignity on the Margins
of Humanity and Beyond, Tel Aviv University, Tel Aviv, Israel, April 7, 2011.
“Resilience, systems and technoscience in synthetic biology,” presented at the BiCoDa
Conference, Center for Interdisciplinary Research, University of Bielefeld, Bielefeld, Germany,
June 29-July 2, 2011.
“Death, the dead donor rule, and human dignity: a critique of technocratic death concepts,”
International Centre for Ethics in the Sciences and Humanities, University of Tubingen,
Tubingen, Germany, Sept 21, 2011.
“Developing guidelines on human subjects research involving nanomedicine: A report on
research associated with an NIH working group,” presented at the USC Workshop on History,
Philosophy, and Ethics of Nanoscale Science and Technology, Columbia, SC, October 5, 2011
“Cross cutting synthesis and discussion overview” for the Committee on Ethical and Societal
Issues in National Security Applications of Emerging Technologies, The National Academy of
Sciences, Beckman Center, Irvine, CA, November 3, 2011.
Discussant (with formal response to Luigi Pellizzoni) for the Panel on Governance of Ethically
Controversial Emerging Technologies, at the Third Annual Conference of the Society for the
Study of Nanosceince and Emerging Technologies, Tempe, Arizona, November 8, 2011.
28
“Why the linear model is so persistent in the framing of medical research,” presented at the
session on Translational Research, Third Annual Conference of the Society for the Study of
Nanosceince and Emerging Technologies (S.NET), Tempe, Arizona, November 9, 2011.
“Ethics, biology, and information,” presented at the Biotechnology, Bioinformatics, and
Intellectual Property Series, UNC-Charlotte, Charlotte, NC, November 17, 2011.
“What kind of ethical reflection is needed for nanotechnology? A case study in upstream ethics,”
Department of Public and Social Administration, City University of Hong Kong, May 2012
Keynote, “Challenges associated with human subjects research in nanomedicine,” 5th Annual
Conference on Bioethics in China, Central South University, Changsha, China, May 6, 2012
“On the ethics of using brain machine interfaces for human enhancement,” Dalian University of
Technology, Dalian, China, May 2012
“Does human subjects research with nanotherapeutic agents require special oversight?”, Invited
Speaker for the International Academy of Nanomedicine (IANM), Third World Congress,
Ankara, Turkey, June 28, 2012
Keynote, “Why synthetic biology needs an ethic of responsible practices,” International
Conference, Ethics and Politics of Emerging Technologies (EPET), Maastricht, The Netherlands,
July 2012
Keynote, Can we develop useful regulatory guidelines that treat nanomaterials as a special class,
6th International Conference on Nanotoxicology, Beijing, China, Sept 2012
“Doctor, something isn’t right: on the techne of transforming a patient’s lack of ease in a
disease,” Invited speaker for Athens Dialogues: Science, Technology, and Ethics, Harvard
University, Boston, MA, November 2012
“Taking the ethical pause,” Grand Rounds, Department of Obstetrics and Gynecology, USC
School of Medicine, January 15, 2013
“Death as a biological concept,” TRIP Conference on death concepts, Columbia, SC, April 2013
“Standardizing clinical judgment: on the logic of quality improvement initiatives at US
Hospitals,” delivered at the States’ Stakes in Science, Center for Interdisciplinary Research (ZiF),
Bielefeld, Germany, July 10, 2013.
“Economics and ethics: The role of government in healthcare,” invited speaker for Straight Talk:
Healthcare Reform in South Carolina, Furman University, Greenville, SC, July 17, 2013
“Responsible conduct in synthetic biology: proactively managing biosafety,” Invited speaker for
7th International Conference on Ethical Issues in Biomedical Engineering, April 13, 2013.
Weissman, J. (presenter) and Khushf, G., “A framework for the flourishing of ‘big science,’ 7th
International Conference on Ethical Issues in Biomedical Engineering, April 2013
29
Panel Member on “The death of death: A scientific and philosophical discussion on
transhumanism,” hosted by USC chapter of the American Society for Biochemistry and
Molecular Biology, November 22, 2013.
“Defense of a neurological criterion for determining death,” Panel on Death and Organ Donation
(with Don Marquis, Michael Nair-Collins, and Walter Sinnott-Armstrong) sponsored by the
Committee on Philosophy and Medicine, Pacific Conference of the American Philosophical
Society, April 19, 2014.
“Why clarification of ethical and legal challenges associated with emerging technologies is a hard
problem,” delivered at the conference, Governance of Emerging Technologies, Arizona State
University, May 28, 2014
“Can the biological sciences tell us when a human must be dead?,” Conference on the Ends of
Life: Deepening Reflection on the Ethical Issues at the Beginning and End of Life, sponsored by
The Edmond J. Safra Center for Ethics, Tel-Aviv University, Tel-Aviv, Israel, June 10, 2014.
Risk and Biosafety, Workshop on Research Agendas in the Societal Aspects of Synthetic
Biology, sponsored by the National Science Foundation, Tempe Mission Palms, Tempe, AZ,
November 4-6, 2014.
“Demonstrating catapults: Two ways of relating pictures and proofs,” delivered at the TRIP
Conference, Pictures and Proofs, University of South Carolina, Columbia, SC, March 20, 2015.
“Why bioengineers cannot sharply distinguish technical questions of feasibility from ethical
questions of permissibility,” invited talk for the 8th International Conference on Ethics in Biology,
Engineering & Medicine, Suny Downstate Medical Center, April 24, 2015.
“How to think about responsible governance of emerging technologies,” presented at a
Conference on Ethical Issues of Converging Technologies and Their Governance, 527th
Xiangshan Science Conference, Bureau of Basic Research, Chinese Academy of Sciences,
Beijing, China, May 13, 2015.
“Aristotle on Virtue,” “Human-Machine Interfaces and the Virtue Acquisition Problem,” and
“Convergence, Enhancement, and Virtue,” three university lectures at Dalian University of
Technology, Dalian, China, May 18 and 21, 2015.